Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDMO
Pharma
Leqembi, Takeda, Fujifilm Diosynth—Fierce Pharma Asia
Medicare's spending projection on Leqembi is way higher than Eisai's own estimates. Takeda partnered with Kumquat. Fujifilm restructured a CDMO unit.
Angus Liu
Apr 19, 2024 9:20am
Geopolitical tensions, Carvykti, Enhertu—Fierce Pharma Asia
Apr 12, 2024 8:20am
CDMO Ascend links up with gene therapy firm Beacon Therapeutics
Apr 9, 2024 10:59am
Thermo Fisher to lay off staffers at California plasmids plant
Apr 9, 2024 8:17am
Eisai, Carvykti, Ozempic biosimilar—Fierce Pharma Asia
Apr 5, 2024 8:25am
Teva inks cancer biosimilar marketing pact with mAbxience
Apr 4, 2024 10:33am